Dr. Kais I. Alsharif, MD

Dr. Alsharif practices at Interventional Spine Center - Laguna Hills in Laguna Hills, California.

Dr. Alsharif's NPI, 1730380007, was assigned on May 31, 2007. Dr. Alsharif graduated from University Of Minnesota Medical School in 2006. Dr. Alsharif holds California license A105368.

Dr. Alsharif's primary practice is Interventional Spine Center - Laguna Hills, at 24012 Calle De Plata, Laguna Hills, CA 92653 in Orange County. The practice phone is (949) 588-7246.

Dr. Alsharif's primary practice is Interventional Spine Center - Laguna Hills in Laguna Hills, California. The medical group on file is Pain Management Associates. Dmand AI also links Dr. Alsharif to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alsharif practices. Vendor and product names are available with a free account.

Interventional pain medicine is Dr. Alsharif's primary specialty in the NPI Registry, under taxonomy code 208VP0014X. Dr. Alsharif is board certified in pain medicine by the American Board of Physical Medicine and Rehabilitation. Dmand AI has Dr. Alsharif's licenses on file in 2 states: California and Minnesota.

Dmand AI lists arthritis, back pain injection, fibromyalgia and chronic pain, joint pain, lower back pain, muscle pain, fibromyalgia, and limb pain, neck pain and spine problems and rotator cuff injury among the conditions Dr. Alsharif treats.

CMS data shows 3,207 Medicare services from Dr. Alsharif across 16 procedure codes in 2024, for 327 Medicare patients. Medicare paid $210,757 for them.

CMS counts 327 Medicare patients who saw Dr. Alsharif in 2024. The largest group is 65 to 74, with 153 patients. 75% of them have arthritis, and 75% have high blood pressure. 42% are also on Medicaid. Their average risk score is 1.45, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Alsharif's median patient age at 66, with 59% women.

In 2024, Dr. Alsharif wrote 686 Medicare Part D claims for 273 patients. 98% of them were for generic drugs. CMS names the drug for 603 of them, across 11 drugs with 11 or more claims each, at $6,930 in total drug cost. In 2023, CMS named 770 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Alsharif for performance year 2024, reported as part of a group. Dr. Alsharif accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Alsharif as offering telehealth.

Dmand AI links 2 papers to Dr. Alsharif. Dr. Alsharif's most frequent co-authors are Andrea J. Boon, MD, Eric Y. Chang, MD and Simon Dardashti, MD.

CMS Open Payments shows 48 general payments to Dr. Alsharif from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abbott Laboratories paid the most, $358.

Dr. Alsharif graduated from University Of Minnesota Medical School in 2006.

Dr. Alsharif is in network with 12 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.